A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...

Lilly sues four telehealth firms for unauthorized compounding of Mounjaro and Zepbound. 2. GLP 1 drugs remain in high demand ...

You can reach Katie on Signal at palmer.01. Amid ongoing battles over alternate supplies of blockbuster weight loss drugs, Eli Lilly filed new lawsuits against four telehealth firms and their ...

Eli Lilly has unleashed another wave of litigation against four telehealth brands in its widening legal war with sellers of alternative versions of its popular diabetes and weight-loss drugs.

Eli Lilly (LLY) is among the list of large-cap pharmaceutical companies that are awaiting the Trump administration's word on tariffs on the industry. Trump's Department of Commerce is looking into ...

Eli Lilly, the drugmaker with two weight-loss bestsellers ... Novo saw the decision as a victory. “With the end of the shortage…no patient should have to be exposed to unsafe, inauthentic ...

Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

Eli Lilly's stock boomed April 17 after announcing a new experimental pill that caused nearly 8% weight loss at certain dosages and lowered blood sugar in patients during a clinical trial.

Eli Lilly (LLY) is among the list of large-cap ... be enough to weaken the threat of tariffs on the sector. "Declare victory and move on [would] be my advice," he said. Anjalee Khemlani is the ...

Eli Lilly (LLY) is among the list of large-cap pharmaceutical companies ... stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any ...